Cascadian Therapeutics Inc (NASDAQ:CASC)

9.99
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
3.18
Today|||52-Week Range
10.21
+170.00%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Cascadian Therapeutics Inc have a median target of 11.50, with a high estimate of 13.00 and a low estimate of 10.00. The median estimate represents a +15.12% increase from the last price of 9.99.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Cascadian Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$0.00
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.89%
 
 
 
 
 
 
Growthannually 60.22%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
Key to the earnings and sales forecast charts.